Christine Ocampo, Vice President, Finance at AVANIR PHARMACEUTICALS, INC. (AVNR), sold 2,080 shares at $11.81 ($25K) on 2014-10-24, disclosed to the SEC on 2014-10-24.
Scheduled sale ($25k) by Vice President, Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AVNR | SELL | 2014-09-17 | $520K | — | Filing → |
| AVNR | SELL | 2014-08-28 | $13K | — | Filing → |
| AVNR | SELL | 2014-05-16 | $189K | — | Filing → |